J Hardy1, N Pollock1, T Gingrich1, P Sweet1, A Ramesh1, J Kuong1, A Basar1, H Jiang1, K Hwang2, J Vukina2, T Jaffe3, M Olszewska4, M Kurpisz4, A N Yatsenko5,6,7. 1. Department of OBGYN and Reproductive Sciences, Magee-Womens Research Institute, School of Medicine, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, 15213, USA. 2. Department of Urology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 3. Department of Urology, School of Medicine, West Virginia University, Morgantown, WV, USA. 4. Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland. 5. Department of OBGYN and Reproductive Sciences, Magee-Womens Research Institute, School of Medicine, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, 15213, USA. yatsenkoan@mwri.magee.edu. 6. Department of Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States. yatsenkoan@mwri.magee.edu. 7. Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States. yatsenkoan@mwri.magee.edu.
Abstract
PURPOSE: To identify clinically significant genomic copy number (CNV) and single nucleotide variants (SNV) in males with unexplained spermatogenic failure (SPGF). MATERIALS AND METHODS: Peripheral blood DNA from 97/102 study participants diagnosed with oligozoospermia, severe oligozoospermia, or non-obstructive azoospermia (NOA) was analyzed for CNVs via array comparative genomic hybridization (aCGH) and SNVs using whole-exome sequencing (WES). RESULTS: Of the 2544 CNVs identified in individuals with SPGF, > 90% were small, ranging from 0.6 to 75 kb. Thirty, clinically relevant genomic aberrations, were detected in 28 patients (~ 29%). These included likely diagnostic CNVs in 3/41 NOA patients (~ 7%): 1 hemizygous, intragenic TEX11 deletion, 1 hemizygous DDX53 full gene deletion, and 1 homozygous, intragenic STK11 deletion. High-level mosaicism for X chromosome disomy (~ 10% 46,XY and ~ 90% 47,XXY) was also identified in 3 of 41 NOA patients who previously tested normal with conventional karyotyping. The remaining 24 CNVs detected were heterozygous, autosomal recessive carrier variants. Follow-up WES analysis confirmed 8 of 27 (30%) CNVs (X chromosome disomy excluded). WES analysis additionally identified 13 significant SNVs and/or indels in 9 patients (~ 9%) including X-linked AR, KAL1, and NR0B1 variants. CONCLUSION: Using a combined genome-wide aCGH/WES approach, we identified pathogenic and likely pathogenic SNVs and CNVs in 15 patients (15%) with unexplained SPGF. This value equals the detection rate of conventional testing for aneuploidies and is considerably higher than the prevalence of Y chromosome microdeletions. Our results underscore the importance of comprehensive genomic analysis in emerging diagnostic testing of complex conditions like male infertility.
PURPOSE: To identify clinically significant genomic copy number (CNV) and single nucleotide variants (SNV) in males with unexplained spermatogenic failure (SPGF). MATERIALS AND METHODS: Peripheral blood DNA from 97/102 study participants diagnosed with oligozoospermia, severe oligozoospermia, or non-obstructive azoospermia (NOA) was analyzed for CNVs via array comparative genomic hybridization (aCGH) and SNVs using whole-exome sequencing (WES). RESULTS: Of the 2544 CNVs identified in individuals with SPGF, > 90% were small, ranging from 0.6 to 75 kb. Thirty, clinically relevant genomic aberrations, were detected in 28 patients (~ 29%). These included likely diagnostic CNVs in 3/41 NOA patients (~ 7%): 1 hemizygous, intragenic TEX11 deletion, 1 hemizygous DDX53 full gene deletion, and 1 homozygous, intragenic STK11 deletion. High-level mosaicism for X chromosome disomy (~ 10% 46,XY and ~ 90% 47,XXY) was also identified in 3 of 41 NOA patients who previously tested normal with conventional karyotyping. The remaining 24 CNVs detected were heterozygous, autosomal recessive carrier variants. Follow-up WES analysis confirmed 8 of 27 (30%) CNVs (X chromosome disomy excluded). WES analysis additionally identified 13 significant SNVs and/or indels in 9 patients (~ 9%) including X-linked AR, KAL1, and NR0B1 variants. CONCLUSION: Using a combined genome-wide aCGH/WES approach, we identified pathogenic and likely pathogenic SNVs and CNVs in 15 patients (15%) with unexplained SPGF. This value equals the detection rate of conventional testing for aneuploidies and is considerably higher than the prevalence of Y chromosome microdeletions. Our results underscore the importance of comprehensive genomic analysis in emerging diagnostic testing of complex conditions like male infertility.
Authors: Alexander N Yatsenko; Svetlana A Yatsenko; John W Weedin; Amy E Lawrence; Ankita Patel; Sandra Peacock; Martin M Matzuk; Dolores J Lamb; Sau Wai Cheung; Larry I Lipshultz Journal: J Urol Date: 2010-02-20 Impact factor: 7.450
Authors: Ewa Wiland; Alexander N Yatsenko; Archana Kishore; Halina Stanczak; Agata Zdarta; Marcin Ligaj; Marta Olszewska; Jan Karol Wolski; Maciej Kurpisz Journal: Reprod Biomed Online Date: 2015-05-07 Impact factor: 3.828
Authors: M J Wyrwoll; E S van Walree; G Hamer; N Rotte; M M Motazacker; H Meijers-Heijboer; M Alders; A Meißner; E Kaminsky; M Wöste; C Krallmann; S Kliesch; T J Hunt; A T Clark; S Silber; B Stallmeyer; C Friedrich; A M M van Pelt; I B Mathijssen; F Tüttelmann Journal: Hum Reprod Date: 2021-12-27 Impact factor: 6.918
Authors: Margot J Wyrwoll; Şehime G Temel; Liina Nagirnaja; Manon S Oud; Alexandra M Lopes; Godfried W van der Heijden; James S Heald; Nadja Rotte; Joachim Wistuba; Marius Wöste; Susanne Ledig; Henrike Krenz; Roos M Smits; Filipa Carvalho; João Gonçalves; Daniela Fietz; Burcu Türkgenç; Mahmut C Ergören; Murat Çetinkaya; Murad Başar; Semra Kahraman; Kevin McEleny; Miguel J Xavier; Helen Turner; Adrian Pilatz; Albrecht Röpke; Martin Dugas; Sabine Kliesch; Nina Neuhaus; Kenneth I Aston; Donald F Conrad; Joris A Veltman; Corinna Friedrich; Frank Tüttelmann Journal: Am J Hum Genet Date: 2020-07-15 Impact factor: 11.025
Authors: Jimmaline J Hardy; Margot J Wyrwoll; William Mcfadden; Agnieszka Malcher; Nadja Rotte; Nijole C Pollock; Sarah Munyoki; Maria V Veroli; Brendan J Houston; Miguel J Xavier; Laura Kasak; Margus Punab; Maris Laan; Sabine Kliesch; Peter Schlegel; Thomas Jaffe; Kathleen Hwang; Josip Vukina; Miguel A Brieño-Enríquez; Kyle Orwig; Judith Yanowitz; Michael Buszczak; Joris A Veltman; Manon Oud; Liina Nagirnaja; Marta Olszewska; Moira K O'Bryan; Donald F Conrad; Maciej Kurpisz; Frank Tüttelmann; Alexander N Yatsenko Journal: Hum Genet Date: 2021-05-07 Impact factor: 5.881
Authors: Manon S Oud; Ludmila Volozonoka; Roos M Smits; Lisenka E L M Vissers; Liliana Ramos; Joris A Veltman Journal: Hum Reprod Date: 2019-05-01 Impact factor: 6.918